Author

Ndidi Onwudiwe

Institution: Sarcoma Alliance for Research through Collaboration

Observed institution: Sarcoma Alliance for Research through Collaboration

OpenAlex ID: A5082189692

Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)

2019 · Brigitte C. Widemann, Yao Lu, et al. · Sarcoma · 74

SARC016: Phase II study of everolimus in combination with bevacizumab in sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST).

2016 · Brigitte C. Widemann, Christian Frederick Meyer, et al. · Journal of Clinical Oncology · 27

Works count: 2

Citation count: 101

H-index: 2

I10-index: 2